GGT6 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:124975, GGT6, HGNC:26891, MIM:612341, NM_001122890, NM_001288702, NM_001288703, NM_001288704, NM_153338, NP_001116362, NP_001275631, NP_001275632, NP_001275633, NP_699169, XM_024450572, XM_024450573, XP_024306340, XP_024306341, gamma-glutamyltransferase 6

Omim:OMIM:612341

Id:832544d0-aca4-5963-b956-b0cf0984f51f

Hgnc:HGNC:26891

Entrez:124975

Ensembl:ENSG00000167741

Description:gamma-glutamyltransferase 6

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GGT6's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GGT6.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GGT6.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GGT6.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GGT6.

Results found

Linked to

	Label	Description
	GSE135514 dasatinib 8 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 7 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE150895 GSE150896 enzalutamide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE118548 1 V 0 TRAMETINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE125014 enzalutamide prostate gland 6 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 8 V 0 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158632 quinoline HT-29 Caco-2 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 2 V 0 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE135514 dasatinib 8 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 14 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE150895 GSE150896 enzalutamide 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE118548 1 V 0 TRAMETINIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE125014 enzalutamide prostate gland 6 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 14 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE135514 8 V 0 DASATINIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE135514 dasatinib 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE158632 quinoline HT-29 Caco-2 3 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE135514 2 V 0 DASATINIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.